Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petta

Showing results (671-680 of 736) with videos related to

Pageof 74
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLDGrazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2025
A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort StudyHo Soo Chun, Minjong Lee, Hye Ah Lee, et al.
Hepatology (Baltimore, Md.)|December 16, 2025
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLDXiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Gut|March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetesYuping Chen, Bingtian Dong, Xinrui Jin, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Scientific Reports|June 17, 2018
The germline mutational landscape of BRCA1 and BRCA2 in BrazilEdenir Inêz Palmero, Dirce Maria Carraro, Barbara Alemar, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021Gong Feng, Giovanni Targher, Christopher D Byrne, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 74

Showing results (671-680 of 736) with videos related to

Sort By:
Pageof 74
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLDGrazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 11, 2025
A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort StudyHo Soo Chun, Minjong Lee, Hye Ah Lee, et al.
Hepatology (Baltimore, Md.)|December 16, 2025
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLDXiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Gut|March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetesYuping Chen, Bingtian Dong, Xinrui Jin, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Scientific Reports|June 17, 2018
The germline mutational landscape of BRCA1 and BRCA2 in BrazilEdenir Inêz Palmero, Dirce Maria Carraro, Barbara Alemar, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021Gong Feng, Giovanni Targher, Christopher D Byrne, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 74